These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8334809

  • 21. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome.
    Koomans HA, Geers AB, vd Meiracker AH, Roos JC, Boer P, Dorhout Mees EJ.
    Am J Nephrol; 1984; 4(4):227-34. PubMed ID: 6383042
    [Abstract] [Full Text] [Related]

  • 22. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
    Brown EA, Markandu N, Sagnella GA, Jones BE, MacGregor GA.
    Nephron; 1985; 39(4):290-5. PubMed ID: 3982574
    [Abstract] [Full Text] [Related]

  • 23. Evidence that some mechanism other than the renin system causes sodium retention in nephrotic syndrome.
    Brown EA, Markandu ND, Sagnella GA, Squires M, Jones BE, MacGregor GA.
    Lancet; 1982 Dec 04; 2(8310):1237-40. PubMed ID: 6128546
    [Abstract] [Full Text] [Related]

  • 24. [The renal systems regulating water-electrolyte balance in the nephrotic syndrome].
    Kutyrina IM, Rogov VA, Zverev KV.
    Ter Arkh; 1991 Dec 04; 63(6):26-30. PubMed ID: 1948737
    [Abstract] [Full Text] [Related]

  • 25. GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis.
    Johannsson G, Sverrisdóttir YB, Ellegård L, Lundberg PA, Herlitz H.
    J Clin Endocrinol Metab; 2002 Apr 04; 87(4):1743-9. PubMed ID: 11932310
    [Abstract] [Full Text] [Related]

  • 26. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T, Marion DN, Camargo MJ, Kleinert HD, Laragh JH, Vaughan ED, Atlas SA.
    Am J Med; 1984 Dec 04; 77(6):1069-75. PubMed ID: 6239544
    [Abstract] [Full Text] [Related]

  • 27. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B, Eiskjaer H, Mogensen CE, Sørensen SS, Pedersen EB.
    Nephron; 1995 Dec 04; 71(1):44-53. PubMed ID: 8538848
    [Abstract] [Full Text] [Related]

  • 28. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
    Hisanaga S, Yamamoto Y, Kida O, Kato J, Fujimoto S, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1989 Jun 04; 31(6):661-9. PubMed ID: 2529385
    [Abstract] [Full Text] [Related]

  • 29. Edema of the nephrotic syndrome: the role of the atrial peptide system.
    Perico N, Remuzzi G.
    Am J Kidney Dis; 1993 Sep 04; 22(3):355-66. PubMed ID: 8372830
    [Abstract] [Full Text] [Related]

  • 30. Importance of the renin-angiotensin system in sodium regulation in essential hypertension.
    Kawabe H, Furukawa T, Takenaka T, Saito I, Saruta T.
    Am J Hypertens; 1991 Feb 04; 4(2 Pt 1):119-25. PubMed ID: 1826997
    [Abstract] [Full Text] [Related]

  • 31. Filtration dynamics and natriuretic response to volume expansion in humans.
    Loon N, Chagnac A, Parra L, Schmidt K, Deen WM, Myers BD.
    Am J Physiol; 1992 Aug 04; 263(2 Pt 2):F284-92. PubMed ID: 1380773
    [Abstract] [Full Text] [Related]

  • 32. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ, Kompanowska-Jezierska E, Wamberg S, Bie P.
    Acta Physiol Scand; 2005 Jul 04; 184(3):225-34. PubMed ID: 15954990
    [Abstract] [Full Text] [Related]

  • 33. Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndrome.
    Woolf AS, Lyon TL, Hoffbrand BI, Cohen SL, Moult PJ.
    Nephron; 1989 Jul 04; 52(3):244-50. PubMed ID: 2544821
    [Abstract] [Full Text] [Related]

  • 34. Role of atrial natriuretic factor in impaired sodium excretion of normocapnic and hypercapnic patients with chronic obstructive lung disease.
    Adnot S, Sediame S, Defouilloy C, Andrivet P, Viossat I, Brun-Buisson C, Chabrier PE, Laurent D.
    Am Rev Respir Dis; 1993 Oct 04; 148(4 Pt 1):1049-55. PubMed ID: 8214924
    [Abstract] [Full Text] [Related]

  • 35. Natriuretic response to head-out immersion in humans with recent kidney transplants.
    Rabelink TJ, van Tilborg KA, Hené RJ, Koomans HA.
    Clin Sci (Lond); 1993 Oct 04; 85(4):471-7. PubMed ID: 8222514
    [Abstract] [Full Text] [Related]

  • 36. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Hypertens; 1996 Jan 04; 14(1):99-106. PubMed ID: 12013501
    [Abstract] [Full Text] [Related]

  • 37. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B, Sørensen SS, Pedersen EB.
    Nephrol Dial Transplant; 1991 Jan 04; 6(6):402-9. PubMed ID: 1652115
    [Abstract] [Full Text] [Related]

  • 38. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis LM.
    Hepatology; 1993 Sep 04; 18(3):519-28. PubMed ID: 8395457
    [Abstract] [Full Text] [Related]

  • 39. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion.
    Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, Pandey KN.
    Am J Physiol Renal Physiol; 2003 Oct 04; 285(4):F694-702. PubMed ID: 12824076
    [Abstract] [Full Text] [Related]

  • 40. [Atrial natriuretic peptide in children with nephrotic syndrome].
    Jovanovitsh O, Popovitsh-Rolovitsh M, Radoshevitsh P, Stankovitsh R, Dujitsh A, Gajitsh M, Peco-Antitsh A, Krushchitsh D, Kostitsh M.
    Srp Arh Celok Lek; 1995 Oct 04; 123(11-12):291-4. PubMed ID: 16296241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.